🇺🇸 FDA
Pipeline program

Lithium Carbonate

LP-DP-09201

Phase 2 small_molecule completed

Quick answer

Lithium Carbonate for Major Depressive Disorder is a Phase 2 program (small_molecule) at NORTHWEST BIOTHERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NORTHWEST BIOTHERAPEUTICS INC
Indication
Major Depressive Disorder
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials